Health Trials

Hematologic Disorders

2

Review clinical trials related to Hematologic Disorders. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation

This study is an investigator-initiated prospective, single-center, open-label clinical trial designed to evaluate the clinical efficacy and safety of Lusutrombopag in promoting platelet remodeling after allogeneic hematopoietic stem cell transplantation in patients with hematologic disorders.

Participants needed: 45
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: The General Hospital of Western Theater CommandUpdated: Mar 25, 2026Locations: 1
Eligibility criteria

The patient signed an informed consent form and voluntarily participated in the... [+5]

Read more
Status: Recruiting

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

This is a treatment guideline for a second or greater allogeneic hematopoietic stem cell transplant (HSCT) using a reduced intensity conditioning (RIC) in patients with non-malignant or malignant diseases. This regimen, consisting of busulfan, fludarabine, and low dose total body irradiation (TBI), is designed to promote engraftment in patients who failed to achieve an acceptable level of donor-derived engraftment following a previous allogeneic HCT.

Participants needed: 30
Trial details
Age: Up to 55Biological sex: AllType: InterventionalSponsor: Masonic Cancer Center, University of MinnesotaUpdated: Jul 24, 2025Locations: 1
Eligibility criteria

Diagnosis of any disease for which a second or greater hematopoietic stem cell t... [+7]

Previous irradiation that precludes the safe administration of an additional dos... [+4]

Read more